J&J’s Spravato nasal spray received a label expansion on Tuesday, now approved as a standalone treatment for major depressive ...

Stanford University professor Irv Weissman and a colleague published a paper that represented a new way to target some ...

A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...

The Trump administration’s decision to withdraw from the World Health Organization could complicate US access to health ...

Meena Seshamani believes the landmark Inflation Reduction Act will “lay the foundation” for future drug price negotiations ...

A father-and-son biotech with ties to Iceland and Philadelphia has put together a €26.5 million Series A to develop oral ...

Ascentage Pharma seeks $133M via US listing, markets olverembatinib in China with Takeda holding global rights. CEO Dajun ...

UnitedHealth's OptumRx to pass 100% of drug rebates to clients by 2028, but critics say GPO structure may still hide true ...

A revived legal challenge to the abortion pill mifepristone will be an early test for President Donald Trump’s administration ...

RTW forms Prolium to develop Keymed Biosciences' CD20×CD3 bispecific CM355 outside Asia for $17.5M upfront, part of growing ...

Sionna Therapeutics and Odyssey Therapeutics join Metsera and Maze in filing for IPOs, with Sionna focused on cystic fibrosis ...

Novo Nordisk’s blockbuster GLP-1 products Ozempic and Wegovy are among the next 15 drugs subject to the government’s Medicare ...